Company Filing History:
Years Active: 2023-2025
Title: Anno Koetje: Innovator in Nucleotide Sequencing
Introduction
Anno Koetje is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of nucleotide sequencing, holding a total of 2 patents. His work focuses on innovative methods that enhance the efficiency and accuracy of sequencing applications.
Latest Patents
Koetje's latest patents include groundbreaking methods of sequencing using nucleotides with 3' acetal blocking groups. These embodiments relate to nucleotides that feature acetal 3'-OH blocking groups. Additionally, he has developed methods for utilizing fully functionalized nucleotides containing the 3′ acetal blocking group for sequencing applications. Another notable patent involves nucleosides and nucleotides with 3' acetal blocking groups, which also includes methods for preparing these molecules and their applications in sequencing.
Career Highlights
Anno Koetje is currently associated with Illumina Cambridge Limited, where he continues to push the boundaries of nucleotide technology. His work has been instrumental in advancing the capabilities of sequencing methodologies.
Collaborations
Koetje collaborates with talented individuals in his field, including Antoine Francais and Elena Cressina. Their combined expertise fosters an environment of innovation and discovery.
Conclusion
In summary, Anno Koetje is a key figure in the realm of nucleotide sequencing, with a focus on developing advanced methods that improve sequencing applications. His contributions are paving the way for future advancements in this critical area of research.